Navigation Links
Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO)
Date:12/6/2010

to those described in our annual report on Form 10-K for the year ended December 31, 2009 and 10-Q filings for the quarters ended March 31, 2010, June 30, 2010 and September 30, 2010 filed with the Securities and Exchange Commission, could cause future results to differ materially from the expectations expressed in this press release. The forward-looking statements contained in this press release are made as of the date hereof and may become outdated over time. ViroPharma does not assume any responsibility for updating any forward-looking statements. These forward looking statements should not be relied upon as representing our assessments as of any date subsequent to the date of this press release.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. ViroPharma Receives Complete Response Letter for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Supplement
2. ViroPharma Announces Publication of Cinryze™ (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine
3. ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing
4. Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care
5. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
6. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
7. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
8. Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765
9. Portola Pharmaceuticals Announces Data Presentations Highlighting Syk/JAK Inhibitor Clinical Development Program at 52nd American Society of Hematology Annual Meeting
10. VIDEO from Merck and Co., Inc available on thenewsmarket.com: In Phase III Study Mercks Investigational CETP Inhibitor Anacetrapib Met Safety and Efficacy Endpoints in Patients with CHD
11. Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... KONG , July 27, 2015 Bloomage ... 00963.HK) announces a strategic cooperation with the South Korean ... establish a joint venture Medybloom to develop and promote ... China . Medytox, the ... Korea, and is also the fourth company in the ...
(Date:7/27/2015)... 27, 2015  Cardica, Inc. (Nasdaq: CRDC ) today ... fourth quarter ended June 30, 2015, on Thursday, August 6, ... conference call at 4:30 p.m. Eastern Time to discuss the ... Conference Call Details To access the live ... Time via phone, please dial 877-703-6106 from the ...
(Date:7/27/2015)... Research and Markets ( http://www.researchandmarkets.com/research/7lz2fk/intraoperative ) has announced the ... (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) , by Geography ... 2019" report to their offering. ... $2.1 Billion by 2019 from $1.8 Billion in 2014, ... The intraoperative imaging market is divided ...
Breaking Medicine Technology:Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 2Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 3Cardica To Announce Fiscal 2015 Fourth Quarter Financial Results On Thursday, August 6, 2015 2Global Intraoperative Imaging (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) Market Forecasts & Trends 2015-2019 2
... Wash., Feb. 21, 2011 Royal Philips Electronics NV ... MSFT ) today announced the companies will collaborate ... to build and understand the complete clinical context of ... commitment to work together to connect technologies that will ...
... Medical, Inc. (Nasdaq: NXTM ), a leading ... recent independent study which reports that home hemodialysis with ... carbon footprint of therapy conducted with traditional in-center hemodialysis ... delivering superior clinical results is a core competency of ...
Cached Medicine Technology:Philips and Microsoft Collaborate to Streamline Radiology Workflow and Processes 2Philips and Microsoft Collaborate to Streamline Radiology Workflow and Processes 3Independent Study Reports 50% Smaller Carbon Footprint With NxStage System One™ vs. Standard In-Center Hemodialysis Machines 2Independent Study Reports 50% Smaller Carbon Footprint With NxStage System One™ vs. Standard In-Center Hemodialysis Machines 3
(Date:7/28/2015)... ... July 28, 2015 , ... Carol McFarland, ... with discussion and demonstration of specific rehabilitation exercises and treatment protocols in the ... surgical process with an extensive interview conducted by Carol with a board certified ...
(Date:7/28/2015)... ... July 28, 2015 , ... Cupertino orthodontist , ... revolutionary orthodontic treatment that allows patients to straighten teeth even without braces. “The ... imaging technology. You wear each set of aligners for about two weeks, removing ...
(Date:7/27/2015)... ... 2015 , ... Almost a year ago, the US Preventive Services Task ... who are obese and those who are overweight with at least one cardiovascular risk ... any commercial health plan with a program year start after August 26, 2015. But ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... ... and diabetes, are associated with smaller regional brain volumes that may be early ... the journal Radiology. , “We already know that vascular risk factors damage the ...
(Date:7/27/2015)... ... July 28, 2015 , ... ... as a 2015 Professional Woman of the Year. Ms. Baum-Lappe is recognized ... organization of professional women in the country, spanning virtually every industry and profession, ...
Breaking Medicine News(10 mins):Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 2Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 3Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 4Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 5Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 6Health News:Cupertino Invisalign Dentist, Dr. Setareh Mozafari, is Now Offering Complimentary Consultations for Invisalign 2Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 2Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 3Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 3Health News:NAPW Inducts Gilda Baum-Lappe, Journalist / Correspondent of Hollywood Foreign Press Association Into its VIP Woman of the Year Circle 2
... the fifth most common complaint seen in the medical office ... considered a disease of the lungs, organs and tissues of ... tract, or even psychiatric in nature. The common treatments are ... ,A seizure drug may be the answer to quieting ...
... occur each year in the United States. Investigators have been tracking ... years to see how various factors might impact their risk for ... of dementia in those with and without a history of stroke.About ... compared to just 11 percent of those who didn’t have a ...
... improve lifestyle habits may not lower blood pressure in ... ,Researchers investigated whether simple interventions, such as ... intake, and advice for a healthier diet, had more ... 300 patients without an established history of high blood ...
... that about 1 million women in the United ... may encounter // a wide-range of problems while ... that many women find their seizures change in ... menopause. Researchers say hormonal changes may be responsible ...
... diseases such as flu, measles, whooping cough and other ... from coming back. // ,Non-Hodgkin's lymphoma is ... comes back, even after chemotherapy and eventually most of ... their lymphoma. ,The vaccine is made from a ...
... epidemic with the highest incidence rate and a high fatality ... and 299 deaths in a ,population of 6.7 million. ... SARS in Hong Kong. It seems the air may be ... care professionals must take the potential for airborne spread of ...
Cached Medicine News:
Honing compound for knife sharpening, 6 grams net...
Knife sharpening back for Standard Knife, C Profile...
Standard vice clamp, can be fitted instead of Quick Realease Cassette...
... The Cryostage freezing stage is a refrigerated design ... holder, primarily for use with the 8000 sledge ... sledge microtomes. ,The refrigerated stage gives a large ... surface is ridged to provide good adhesion between ...
Medicine Products: